LA BioMed Names Three New Members to its Board – Appointees Bring a Diversity of Experience to the Institute’s Governing Body
LOS ANGELES – (May 29, 2013) – Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center(LA BioMed) has named three new members to its board of directors.
The new members are Alex Popa, a vice president at The Capital Group in Los Angeles; H. Michael Smith, the national science and technology practice leader for HKS, Inc.; and Sussan Sharifian, president of Packair Airfreight, Inc and Packair Customs Brokers, Inc.
LA BioMed Researchers Honored For their Excellence in Clinical and Classroom Teaching – Drs. Carol Berkowitz and Mallory D. Witt Receive Dadone Award
LOS ANGELES – (May 28, 2013) – Carol Berkowitz, MD, and Mallory D. Witt, MD, lead researchers at the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed), received the Serge & Yvette Dadone Clinical Teaching Award in Honor of Saleh Salehmoghaddam, M.D., a peer-reviewed recognition of their “outstanding dedication, innovation, and sustained excellence in clinical and classroom teaching,” according to the David Geffen School of Medicine at UCLA, which presented the awards.
LA BioMed Researchers Receive $1.8 million grant from the National Institutes of Health/National Institute of Allergy and Infectious Diseases
Drs. Arnold Bayer, Yan Qiong Xiong and Soo-Jin Yang, Faculty principal investigators in LA BioMed’s Division of Infectious Diseases, have recently been awarded three extramural grants for their collaborating programs in the study of Staphylococcus aureus infections, most specifically Methicillin-resistant Staphylococcus aureus (MRSA). Dr. Bayer’s $1.8 million grant from the National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIAID) represents continued funding for years 15-19 of this RO1-funded project, while Dr.
LOS ANGELES – (May 23, 2013) – Rubén D. Flores-Saaib, PhD, an experienced professional in the biomedical development field, recently joined the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed) as the assistant vice president for business development, a newly created position to maximize the potential of intellectual property generated by the institute’s 100 investigators.
Six-fold Increase in Risk of Heart Attack and Death With Progressive Coronary Artery Calcium Buildup Study Suggests More Frequent Monitoring Could Save Lives
LOS ANGELES – (May 2, 2013) – Patients with increasing accumulations of coronary artery calcium were more than six times more likely to suffer from a heart attack or die from heart disease than patients who didn’t have increasing accumulations, according to a recent study published in the Journal of the American College of Cardiology.